Evaluation of Electrocardiographic Measurements by High Density Electrode ECG (ECG-HD)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Michel HAÏSSAGUERRE, MD-PhD
- Phone Number: +33 (0)5 57 65 64 71
- Email: michel.haissaguerre@chu-bordeaux.fr
Study Contact Backup
- Name: Aude CATHALA
- Email: aude.cathala@chu-bordeaux.fr
Study Locations
-
-
-
Clermont-Ferrand, France, 63000
- Not yet recruiting
- CHU clermont-ferrand
-
Contact:
- Romain ESCHALIER
- Email: reschalier@chu-clermontferrand.fr
-
Massy, France, 91300
- Not yet recruiting
- Hôpital Privé Jacques Cartier
-
Contact:
- Laurent FIORINA
- Email: contact@rythmo.fr
-
Paris, France, 75013
- Not yet recruiting
- Hôpital Pitié-Salpêtrière
-
Contact:
- Estelle GANDJBAKHCH
- Email: estelle.gandjbakhch@aphp.fr
-
Paris, France, 75018
- Not yet recruiting
- Hôpital Bichat
-
Contact:
- Fabrice EXTRAMANIA
- Email: fabrice.extramania@aphp.fr
-
Paris, France, 75908
- Not yet recruiting
- Hôpital Europeén Georges Pompidou
-
Contact:
- Eloi MARIJON
- Email: eloi.marijon@aphp.fr
-
Pessac, France, 33604
- Recruiting
- Bordeaux University Hospital
-
Contact:
- Michel HAÏSSAGUERRE, MD-PhD
- Phone Number: +33 (0)5 57 65 64 71
- Email: michel.haissaguerre@chu-bordeaux.fr
-
Contact:
- Aude CATHALA
- Email: aude.cathala@chu-bordeaux.fr
-
Contact:
- Frédéric SACHER, MD-PhD
-
Contact:
- Michel HAÏSSAGUERRE, MD-PhD
-
Contact:
- Josselin DUCHATEAU, MD
-
Contact:
- Romain TIXIER, MD
-
Contact:
- Hugo MARCHAND, MD
-
Rennes, France, 35033
- Not yet recruiting
- CHR Pontchaillou
-
Contact:
- Raphaël MARTINS
- Email: raphael.martins@chu-rennes.fr
-
Saint-Etienne, France, 42055
- Not yet recruiting
- CHU de Saint-Etienne
-
Contact:
- Karim BENALI
- Email: karim.benali@univ-st-st-etienne.fr
-
Toulouse, France, 35033
- Not yet recruiting
- CHU de Toulouse
-
Contact:
- Philippe MAURY
- Email: maury.p@chu-toulouse.fr
-
Vandoeuvre les Nancy, France, 54511
- Not yet recruiting
- CHU de Nancy
-
Contact:
- Christian DE CHILLOU
- Email: c.dechillou@chru-nancy.fr
-
-
-
-
-
Monaco, Monaco, 98000
- Not yet recruiting
- Centre Hospitalier Princesse Grace
-
Contact:
- Gabriel LATCU
- Email: gabriel.latcu@chpg.mc
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patient managed at the Bordeaux University Hospital for assessment of documented severe ventricular arrhythmia (VF, sudden resuscitated death) or suspected (syncope, family history of sudden death, ECG or Holter abnormality) or impaired ventricular conduction, OR
- Patients managed for prophylactic ventricular defibrillator implantation, according to international recommendations: Heart disease with ejection fraction < 35%, heart disease with sustained ventricular tachycardia, cardiomyopathies with high rhythmic risk,
- Women of childbearing age with effective contraception.
Exclusion Criteria:
- patients under 14 years old,
- pregnant or nursing woman.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Proven or suspected arrhythmias group
|
This experimental procedure is a passive, non-invasive, high-density surface ECG recording using 128 skin electrodes.The electrodes are positioned on strips of 10 electrodes to be prepared with adhesive tape and coated with conductive gel before installation on the patient.
The total duration of the acquisition is 10 to 30 minutes.
This standard 12-lead ECG is defined on the HD ECG, from electrodes F13, G3, G14, H5, H15, H25 corresponding to the precordial electrodes.
4 limb electrodes will be added for the frontal leads.
Thus, the HD and 12-lead ECGs will be obtained simultaneously.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Identification of the "amplitude" electrical criteria by HD ECG
Time Frame: Day 0
|
These electrical criteria are measured in millivolt (mV)
|
Day 0
|
|
Identification of the "cardiac time" electrical criteria by HD ECG
Time Frame: Day 0
|
Defined by the auricular cardiac time, ventricular depolarization and repolarization time
|
Day 0
|
|
Identification of the "duration" electrical criteria by HD ECG
Time Frame: Day 0
|
These criteria are measured in milliseconds (ms)
|
Day 0
|
|
Identification of "anatomical locations" electrical criteria by HD ECG
Time Frame: Day 0
|
Defined by the position of the electrodes
|
Day 0
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Michel HAÏSSAGUERRE, MD-PhD, University Hospital, Bordeaux
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- CHUBX 2020/59
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.